Scrip Asks…What Does 2024 Hold for Biopharma?
James West, Managing Director in Lincoln’s Healthcare Group, recently discussed his expectations for the biopharma market in 2024 as part of Scrip’s series.
Summary
- Lincoln International’s James West offers Scrip a perspective on the 2024 biopharma market.
- Sign up to receive Lincoln's perspectives